Circulating microRNAs: Novel biomarkers for early detection of colorectal cancer

Translational Research

Volumn 166, Issue 3, 2015, Pages 219-224

  Aravalli, Rajagopal N ^a   Steer, Clifford J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 107; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 200C; MICRORNA 20A; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 223; MICRORNA 29A; MICRORNA 34A;

COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; DOWN REGULATION; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; GENE EXPRESSION REGULATION; HUMAN; NOTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; SENSITIVITY AND SPECIFICITY; TRANSLATION REGULATION; TUMOR GROWTH; TUMOR RECURRENCE; BLOOD; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MALE;

COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS;

EID: 84938951872     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.04.007     Document Type: Note

References (66)

1. American Cancer Society Cancer facts & figures 2012 American Cancer Society Atlanta
2. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
3. M.Y. Carpentier, S.W. Vernon, L.K. Batholomew, C.C. Murphy, and S.M. Bluethmann Receipt of recommended surveillance among colorectal cancer survivors: a systematic review J Cancer Surviv 7 2013 464 483
4. D.G. Pfister, A.B. Benson 3rd, and M.R. Somerfield Clinical practice. Surveillance strategies after curative treatment of colorectal cancer N Engl J Med 350 2004 2375 2382
5. E. Van Cutsem, A. Cervantes, B. Nordlinger, D. Arnold ESMO Guidelines Working Group Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 2014 iii1 iii9
6. A. Shaukat, S.J. Mongin, M.S. Geisser, and et al. Long-term mortality after screening for colorectal cancer N Engl J Med 369 2013 1106 1114
7. R. Garzon, M. Fabbri, A. Cimmino, G.A. Calin, and C.M. Croce MicroRNA expression and function in cancer Trends Mol Med 12 2006 580 587
8. O. Slaby, J. Michalek, and R. Vyzula MicroRNAs in colorectal cancer: translation of molecular biology into clinical application Mol Cancer 8 2009 102
9. M. Liu, and H. Chen The role of microRNAs in colorectal cancer J Genet Geneomics 37 2010 347 358
10. Y. Ma, P. Zhang, J. Yang, Z. Liu, Z. Yang, and H. Qin Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation Int J Cancer 130 2012 2077 2087
11. M. Nugent, N. Miller, and M.J. Kerin MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers Eur J Surg Oncol 37 2011 649 654
12. S.S. Chim, T.K. Shing, E.C. Hung, and et al. Detection and characterization of placental microRNAs in maternal plasma Clin Chem 54 2008 482 490
13. J.A. Weber, D.H. Baxter, S. Zhang, and et al. The microRNA spectrum in 12 body fluids Clin Chem 56 2010 1733 1741
14. Y.F. Xiao, X. Yong, Y.H. Fan, M.H. Lü, S.M. Yang, and C.J. Hu microRNA detection in feces, sputum, pleural effusion and urine: novel tools for cancer screening Oncol Rep 30 2013 535 544
15. F. Russo, S. Di Bella, G. Nigita, and et al. miRandola: extracellular circulating microRNAs database PLoS One 7 2012 e47786
16. F. Russo, S. Di Bella, V. Bonnici, and et al. A knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAs BMC Genomics 15 2014 S4
17. E.K. Ng, W.W. Chong, H. Jin, and et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
18. X. Chen, Y. Ba, L. Ma, and et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
19. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int J Cancer 127 2010 118 126
20. G.H. Liu, Z.G. Zhou, R. Chen, and et al. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer Tumour Biol 34 2013 2175 2181
21. L.G. Wang, and J. Gu Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis Cancer Epidemiol 36 2012 e61 e67
22. Q. Wang, Z. Huang, S. Ni, and et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer PLoS One 7 2012 e44398
23. X. Luo, C. Stock, B. Burwinkel, and H. Brenner Identification and evaluation of plasma microRNAs for early detection of colorectal cancer PLoS One 8 2013 e62880
24. P. Faltejskova, O. Bocanek, M. Sachlova, and et al. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: evidence against their usage as biomarkers in colorectal cancer Cancer Biomark 12 2012 199 204
25. Z. Kanaan, H. Roberts, M.R. Eichenberger, and et al. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer Ann Surg 258 2013 400 408
26. A. Brunet Vega, I. Moya, A. Ferrer, and et al. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers Oncol Rep 30 2013 320 326
27. M. Du, S. Liu, D. Gu, and et al. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients Carcinogenesis 35 2014 2723 2730
28. Y. Toiyama, M. Takahashi, K. Hur, and et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer J Natl Cancer Inst 105 2013 849 859
29. F.L. Yong, C.W. Law, and C.W. Wang Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer BMC Cancer 13 2013 280
30. Y. Toiyama, K. Hur, K. Tanaka, and et al. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer Ann Surg 259 2014 735 743
31. A. Fesler, J. Jiang, H. Zhai, and J. Ju Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients Mol Diagn Ther 18 2014 303 308
32. C.W. Wu, S.S. Ng, Y.J. Dong, and et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps Gut 61 2012 739 745
33. C.W. Wu, S.C. Ng, Y. Dong, and et al. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma Clin Cancer Res 20 2014 2994 3002
34. T.O. Yau, C.W. Wu, Y. Dong, and et al. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma Br J Cancer 111 2014 1765 1771
35. H. Cheng, L. Zhang, D.E. Cogdell, and et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis PLoS One 6 2011 e17745
36. X.X. Pu, G.L. Huang, H.Q. Guo, and et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression J Gastroenterol Hepatol 25 2010 1674 1680
37. G.Y. Ho, J.H. Jung, R.E. Schoen, and et al. Differential expression of circulating miRNAs according to severity of colorectal neoplasia Transl Res 166 2015 225 232
38. E. Hofsli, W. Sjursen, W.S. Prestvik, and et al. Identification of serum microRNA profiles in colon cancer Br J Cancer 108 2013 1712 1719
39. J. Zhang, K. Zhang, M. Bi, X. Jiao, D. Zhang, and Q. Dong Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy Anticancer Drugs 25 2014 346 352
40. B. Wang, and Q. Zhang The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors J Cancer Res Clin Oncol 138 2012 1659 1666
41. Z. Kanaan, S.N. Rai, M.R. Eichenberger, and et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer Ann Surg 256 2012 544 551
42. J.B. Kjersem, T. Ikdahl, O.C. Lingjaerde, T. Guren, K.M. Tveit, and E.H. Kure Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment Mol Oncol 8 2014 59 67
43. H. Ogata-Kawata Circulating exosomal microRNAs as biomarkers of colon cancer PLoS One 9 2014 e92921
44. M.D. Giráldez, J.J. Lozano, G. Ramírez, and et al. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Clin Gastroenterol Hepatol 11 2013 681 688
45. M. Zhong, Z. Bian, and Z. Wu miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma Cell Physiol Biochem 31 2013 209 218
46. Q. Zhang, Q. Tang, D. Qin, and et al. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis Mol Cell Biol 35 2015 988 1000
47. Y.S. Chae, J.G. Kim, S.J. Lee, and et al. A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer Anticancer Res 33 2013 3233 3239
48. A. Figueredo, M.L. Charette, J. Maroun, M.C. Brouwers, and L. Zuraw Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group J Clin Oncol 22 2004 3395 3407
49. S. Gill, C.L. Loprinzi, D.J. Sargent, and et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 2004 1797 1806
50. R. Duttagupta, R. Jiang, J. Gollub, R.C. Getts, and K.W. Jones Impact of cellular miRNAs on circulating miRNA biomarker signatures PLoS One 6 2011 e20769
51. A. Turchinovich, and B. Burwinkel Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma RNA Biol 9 2012 1066 1075
52. L. Li, D. Zhu, L. Huang, and et al. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles PLoS One 7 2012 e46057
53. J. Skog, T. Würdinger, S. van Rijn, and et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 2008 1470 1476
54. J.F. Quackenbush, P.B. Cassidy, L.M. Pfeffer, and et al. Isolation of circulating microRNAs from microvesicles found in human plasma Methods Mol Biol 1102 2014 641 653
55. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J.J. Lee, and J.O. Lötvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
56. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya Secretory mechanisms and intercellular transfer of microRNAs in living cells J Biol Chem 285 2010 17442 17452
57. A. Zernecke, K. Bidzhekov, H. Noels, and et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection Sci Signal 2 2009 ra81
58. J. Wolfers, A. Lozier, G. Raposo, and et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Nat Med 7 2001 297 303
59. A. Graser, P. Stieber, D. Nagel, and et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population Gut 58 2009 241 248
60. M.J. Duffy, A. van Dalen, C. Haglund, and et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use Eur J Cancer 43 2007 1348 1360
61. N. Eleftheriadis, C. Papaloukas, and K. Pistevou-Gompaki Diagnostic value of serum tumor markers in asymptomatic individuals J BUON 14 2009 707 710
62. Y.R. Wang, J.X.1 Yan, and L.N. Wang The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer J Cancer Res Ther 10 2014 307 309
63. F.E. Ahmed, P.W. Vos, C. Jeffries, and et al. Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensity-modulated radiation therapy (IMRT), or conventional radiation therapy (RT) Cancer Genomics Proteomics 6 2009 109 127
64. N. Kosaka, H. Iguchi, and T. Ochiya Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis Cancer Sci 101 2010 2087 2092
65. K. Srivastava, and A. Srivastava Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk PLoS One 7 2012 e50966
66. Y. Xu, L. Gu, Y. Pan, and et al. Different effects of three polymorphisms in microRNAs on cancer risk in Asian population: evidence from published literatures PLoS One 8 2013 e65123